• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性全脑照射(PCI)、海马回避(HA)全脑放疗(WBRT)和立体定向放疗(SRS)在小细胞肺癌(SCLC)中的应用:我们处于什么位置?

Prophylactic cranial irradiation (PCI), hippocampal avoidance (HA) whole brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) in small cell lung cancer (SCLC): Where do we stand?

机构信息

Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, United Kingdom.

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

出版信息

Lung Cancer. 2021 Dec;162:96-105. doi: 10.1016/j.lungcan.2021.10.016. Epub 2021 Nov 6.

DOI:10.1016/j.lungcan.2021.10.016
PMID:34768007
Abstract

Small cell lung cancer (SCLC) is an aggressive form of lung cancer associated with an increased risk of develping brain metastases (BM), which are a significant cause of morbidity and mortality. Prophylactic cranial irradiation (PCI) was first introduced in the 1970s with the aim of reducing BM incidence and improving survival and quality of life (QoL). Prospective clinical trials and meta-analyses have demonstrated its effectiveness in reducing BM incidence and improving survival, across all stages of the disease following response to induction chemotherapy. Despite its long history, "unknowns" surrounding PCI use still exist and there are particular subgroups of patients for which its use remains controversial. PCI is known to cause neurocognitive toxicity which can have a significant impact on a patient's QoL. Strategies to minimise this, including the use of hippocampal avoidance radiotherapy techniques, neuroprotective drugs and stereotactic radiosurgery in place of whole brain radiotherapy for the treatment of BM, are under evaluation. This review offers a summary of the key PCI trials published to date and the current treatment recommendations based on available evidence. It also discusses the key questions being addressed in ongoing clinical trials and highlights others where there is currently a knowledge gap and therefore where further data are urgently required.

摘要

小细胞肺癌(SCLC)是一种侵袭性肺癌,其发生脑转移(BM)的风险增加,脑转移是发病率和死亡率的重要原因。预防性颅脑照射(PCI)于 20 世纪 70 年代首次引入,目的是降低 BM 的发生率,提高生存率和生活质量(QoL)。前瞻性临床试验和荟萃分析表明,在诱导化疗后疾病各阶段,它在降低 BM 的发生率和提高生存率方面具有有效性。尽管 PCI 的应用历史悠久,但仍存在一些“未知”因素,并且对于某些特定患者群体,其应用仍然存在争议。PCI 会导致神经认知毒性,这会对患者的 QoL 产生重大影响。目前正在评估一些策略来最大程度地减少这种毒性,包括使用海马回避放射治疗技术、神经保护药物和立体定向放射外科治疗 BM,而不是全脑放疗。这篇综述总结了迄今为止发表的关键 PCI 试验和基于现有证据的当前治疗建议。它还讨论了正在进行的临床试验中需要解决的关键问题,并强调了其他存在知识空白的问题,因此迫切需要进一步的数据。

相似文献

1
Prophylactic cranial irradiation (PCI), hippocampal avoidance (HA) whole brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) in small cell lung cancer (SCLC): Where do we stand?预防性全脑照射(PCI)、海马回避(HA)全脑放疗(WBRT)和立体定向放疗(SRS)在小细胞肺癌(SCLC)中的应用:我们处于什么位置?
Lung Cancer. 2021 Dec;162:96-105. doi: 10.1016/j.lungcan.2021.10.016. Epub 2021 Nov 6.
2
Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.接受过预防性颅脑照射后因脑转移而再次接受照射的小细胞肺癌患者的预后。
Lung Cancer. 2016 Nov;101:76-81. doi: 10.1016/j.lungcan.2016.09.010. Epub 2016 Sep 14.
3
Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era.免疫治疗时代广泛期小细胞肺癌的放射治疗。
Front Immunol. 2023 Aug 28;14:1132482. doi: 10.3389/fimmu.2023.1132482. eCollection 2023.
4
Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.在局限期小细胞肺癌中采用海马体回避的预防性颅脑照射的成本效益
Radiother Oncol. 2017 Mar;122(3):411-415. doi: 10.1016/j.radonc.2017.01.005. Epub 2017 Jan 18.
5
Should Stereotactic Radiosurgery Be Considered for Salvage of Intracranial Recurrence after Prophylactic Cranial Irradiation or Whole Brain Radiotherapy in Small Cell Lung Cancer? A Population-Based Analysis and Literature Review.预防性颅脑照射或全脑放疗后颅内复发生存不良时,是否应考虑立体定向放射外科治疗?基于人群的分析和文献复习。
J Med Imaging Radiat Sci. 2020 Mar;51(1):75-87.e2. doi: 10.1016/j.jmir.2019.10.001. Epub 2019 Nov 20.
6
Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.研究方案:对局限期小细胞肺癌患者进行观察而不是 PCI-前瞻性、多中心单臂研究。
BMC Cancer. 2020 Mar 18;20(1):231. doi: 10.1186/s12885-020-06721-8.
7
Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.随机 III 期临床试验:预防性全脑放疗联合或不联合海马回避治疗小细胞肺癌(PREMER):GICOR-GOECP-SEOR 研究。
J Clin Oncol. 2021 Oct 1;39(28):3118-3127. doi: 10.1200/JCO.21.00639. Epub 2021 Aug 11.
8
Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.小细胞肺癌患者初诊时和颅放疗后发生海马转移的风险:预防性或治疗性颅放疗中保护海马的安全性研究。
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):781-6. doi: 10.1016/j.ijrobp.2014.12.026.
9
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer.小细胞肺癌脑转移的治疗与预防。
Am J Clin Oncol. 2021 Dec 1;44(12):629-638. doi: 10.1097/COC.0000000000000867.
10
Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis.海马和海马旁区脑转移瘤的发生率及其对海马回避放疗的影响:系统评价和荟萃分析。
Radiother Oncol. 2024 Aug;197:110331. doi: 10.1016/j.radonc.2024.110331. Epub 2024 May 19.

引用本文的文献

1
Genomic predictors of radiation response: recent progress towards personalized radiotherapy for brain metastases.放射反应的基因组预测指标:脑转移瘤个体化放射治疗的最新进展
Cell Death Discov. 2024 Dec 18;10(1):501. doi: 10.1038/s41420-024-02270-2.
2
Machine learning-based prediction model for brain metastasis in patients with extensive-stage small cell lung cancer.基于机器学习的广泛期小细胞肺癌脑转移预测模型。
Sci Rep. 2024 Nov 20;14(1):28790. doi: 10.1038/s41598-024-80425-y.
3
Prophylactic cranial irradiation for limited-stage small-cell lung cancer in the modern magnetic resonance imaging era may be omitted: a propensity score-matched analysis.
现代磁共振成像时代,局限期小细胞肺癌的预防性颅脑照射或可省略:一项倾向评分匹配分析
J Radiat Res. 2024 Dec 3;65(6):805-812. doi: 10.1093/jrr/rrae087.
4
The association between graded prognostic assessment and the prognosis of brain metastases after whole brain radiotherapy: a meta-analysis.分级预后评估与全脑放疗后脑转移瘤预后的相关性:一项荟萃分析。
Front Oncol. 2024 Jan 9;13:1322262. doi: 10.3389/fonc.2023.1322262. eCollection 2023.
5
Radiotherapy in Preclinical Models of Brain Metastases: A Review and Recommendations for Future Studies.脑转移瘤的临床前模型中的放射治疗:综述与未来研究建议。
Int J Biol Sci. 2024 Jan 1;20(2):765-783. doi: 10.7150/ijbs.91295. eCollection 2024.
6
Volumetric-Modulated Arc-Based Re-radiosurgery With Simultaneous Reduced-Dose Whole-Brain Irradiation for Local Failures Following Prior Radiosurgery of Brain Oligometastases From Small Cell Lung Cancer.基于容积调强弧形放疗的再程放射外科联合同步减量全脑照射治疗小细胞肺癌脑寡转移瘤既往放射外科治疗后局部复发
Cureus. 2023 Aug 31;15(8):e44492. doi: 10.7759/cureus.44492. eCollection 2023 Aug.
7
Building Team Medicine in the Management of CNS Metastases.组建团队医学以管理中枢神经系统转移瘤
J Clin Med. 2023 Jun 7;12(12):3901. doi: 10.3390/jcm12123901.
8
Differences between Advanced Large Cell Neuroendocrine Carcinoma and Advanced Small Cell Lung Cancer: A Propensity Score Matching Analysis.晚期大细胞神经内分泌癌与晚期小细胞肺癌的差异:一项倾向评分匹配分析
J Cancer. 2023 May 21;14(9):1541-1552. doi: 10.7150/jca.84600. eCollection 2023.
9
Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675).海马回避预防性颅脑照射与预防性颅脑照射随机3期试验(NCT01780675)中,小细胞肺癌患者的自我报告认知功能和生活质量
JTO Clin Res Rep. 2023 Mar 24;4(5):100506. doi: 10.1016/j.jtocrr.2023.100506. eCollection 2023 May.
10
Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer.立体定向体部放射治疗用于颅外寡进展或寡复发小细胞肺癌
Clin Transl Radiat Oncol. 2023 May 3;41:100637. doi: 10.1016/j.ctro.2023.100637. eCollection 2023 Jul.